About Saimirra Innopharm Private Limited
Data last updated: 04 January 2026
Saimirra Innopharm Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 March 2000, the company has been in operation for over 26 years.
Registered with ROC Chennai under CIN U24232TN2000PTC044315.
Capital: an authorised share capital of ₹19.25 Cr and a paid-up capital of ₹16 Cr. It is led by directors including Ayyavu Rajavel and Shanmugam Muthusamy.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 288 & 299 Sidco Estate Ambattur, Chennai, Tamil Nadu, India – 600098.
As per the financials filed for FY 2025, the company reported a revenue of ₹132.6 Cr, a growth of 65% compared to the previous year.
The company has a workforce of approximately 154 employees as per the latest available data.
The company is associated with 3 brands - Saimirra, Dhanasri Finvisory, Jmp Advisors. As per MCA filings, the company has open charges of ₹175.36 Cr and satisfied charges of ₹245.87 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saimirra.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address288 & 299 Sidco Estate Ambattur, Chennai, Tamil Nadu, India – 600098
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited operates multiple associated brands including Saimirra, Dhanasri Finvisory, and JMP Advisors. These brands represent Saimirra Innopharm Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical formulations, API, and CRO services for global markets. | saimirra.com | |
| Offers financial advisory, capital raising, and debt structuring for businesses worldwide. | dsfinv.in | |
| Provides tax advisory, litigation, and compliance for businesses in various sectors. | jmpadvisors.com |
Competitors & Alternatives of Saimirra Innopharm Private Limited
Brands and companies operating in the same space as Saimirra Innopharm Private Limited include Fidelity Investments, UTI Mutual Fund, Goldman Sachs and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Fidelity Investments
|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | Boston, United States, United States | 1946 |
UTI Mutual Fund
|
Mutual funds, portfolio management, and retirement planning services are offered. | Mumbai, India, India | 2001 |
Goldman Sachs
|
Investment banking services are delivered across multiple financial sectors. | New York, United States, United States | 1869 |
S&P Global
|
Platform offering business intelligence solutions that combine data and actionable analytics for clients | New York, United States, United States | 1917 |
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Sundaram Finance
|
Provider of consumer & SME loans and equipment & vehicle leasing services | Chennai, India, India | 1954 |
Bank of America
|
Commercial banking and asset management services are offered worldwide. | Charlotte, United States, United States | 1904 |
State Street
|
Financial services are provided to asset managers worldwide. | Boston, United States, United States | - |
FIS
|
Software suites for banks and financial institutions are provided. | Jacksonville, United States, United States | 1968 |
Avendus
|
Corporate advisory and investment services are provided to clients. | Mumbai, India, India | 1999 |
Business Activity of Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Saimirra Innopharm Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited is audited by Ramesh and Ramachandran for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ramesh and Ramachandran | Locked | Locked | Locked |
Complete auditor history for Saimirra Innopharm Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited is currently managed by 6 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ayyavu Rajavel
Also directs:
Nuray Chemicals Private Limited, Delvin Surgicals Private Limited, Tindivanam Pharma Park Association and 5 more
|
Alternate Director | 22 Oct 2012 | 13 Years 8 Months | Current |
|
Shanmugam Muthusamy
Also directs:
Nuray Chemicals Private Limited, Annamar Pharma Llp, Esjay Pharma Private Limited and 5 more
|
Director | 22 Oct 2012 | 13 Years 8 Months | Current |
|
Jaganathan Jayaseelan
Also directs:
Durujaya Infrastructure Llp, Nuray Chemicals Private Limited, Clan Laboratories Private Limited and 5 more
|
Director | 18 Jul 2012 | 13 Years 11 Months | Current |
| Thanigainathan Thirumurugan | Director | 14 Jun 2013 | 13 Years 1 Months | Current |
| Bernice Sugirtha | Director | 09 Jul 2024 | 2 Years 0 Months | Current |
|
Abhishek Jain
Also directs:
Biodeal Pharmaceuticals Limited, Harmony Organics Private Limited, 3 Gen Consulting Services Private Limited and 1 more
|
Nominee Director | 19 Jul 2025 | 0 Years 11 Months | Current |
Financials of Saimirra Innopharm Private Limited FY 2024 filings available
Saimirra Innopharm Private Limited reported revenue of ₹132.6 Cr (up 65.00% YoY) for FY 2025.
Ten-year financial statements for Saimirra Innopharm Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Saimirra Innopharm Private Limited
Shareholding and ownership data for Saimirra Innopharm Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Saimirra Innopharm Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2025 | Others | ₹160 Cr | Open |
| 31 May 2024 | Others | ₹15 Cr | Open |
| 02 Feb 2024 | Hdfc Bank Limited | ₹36.16 Lakh | Open |
| 24 Feb 2023 | Others | ₹165 Cr | Satisfied |
| 25 Oct 2021 | Others | ₹2 Cr | Satisfied |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited has a workforce of 154 employees as of Mar 25, 2025.
Employee and EPFO history for Saimirra Innopharm Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Saimirra Innopharm Private Limited
GST registrations and filing compliance for Saimirra Innopharm Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Saimirra Innopharm Private Limited
Credit ratings, litigation, and regulatory alerts for Saimirra Innopharm Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Saimirra Innopharm Private Limited
MSME payment history for Saimirra Innopharm Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Saimirra Innopharm Private Limited
Corporate group structure for Saimirra Innopharm Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Saimirra Innopharm Private Limited
MCA filings and documents for Saimirra Innopharm Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Saimirra Innopharm Private Limited
Frequently Asked Questions about Saimirra Innopharm Private Limited
Saimirra Innopharm Private Limited is an active private limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 06 March 2000 (26+ years old) and is registered under CIN U24232TN2000PTC044315. The company has 154 employees.
Saimirra Innopharm Private Limited reported revenue of ₹132.6 Cr for FY 2025 (up 65.00% YoY).
The current directors of Saimirra Innopharm Private Limited are:
- Ayyavu Rajavel - Alternate Director
- Shanmugam Muthusamy - Director
- Jaganathan Jayaseelan - Director
- Thanigainathan Thirumurugan - Director
- Bernice Sugirtha - Director
- Abhishek Jain - Nominee Director
The primary industry of Saimirra Innopharm Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Saimirra Innopharm Private Limited can be reached at the registered office: 288 & 299 Sidco Estate Ambattur, Chennai, Tamil Nadu, India – 600098, or through the website saimirra.com.
The authorised capital is ₹19.25 Cr, and the paid-up capital is ₹16 Cr.